405 related articles for article (PubMed ID: 7543127)
21. Treatment of hypercalcemia.
Attie MF
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):807-28. PubMed ID: 2673775
[TBL] [Abstract][Full Text] [Related]
22. Hypercalcemia and bone resorption in malignancy.
Walls J; Bundred N; Howell A
Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
[TBL] [Abstract][Full Text] [Related]
23. [Bisphosphonates in malignant hypercalcemia and bone pain].
Lamy O
Rev Med Suisse Romande; 2004 Feb; 124(2):111-4. PubMed ID: 15095627
[TBL] [Abstract][Full Text] [Related]
24. Medical treatment of hypercalcemia.
Schaiff RA; Hall TG; Bar RS
Clin Pharm; 1989 Feb; 8(2):108-21. PubMed ID: 2521820
[TBL] [Abstract][Full Text] [Related]
25. Hypercalcemia of malignancy--new insights into an old syndrome.
Esbrit P
Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
[TBL] [Abstract][Full Text] [Related]
26. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
[TBL] [Abstract][Full Text] [Related]
27. [Pathophysiology and treatment of malignancy-associated hypercalcemia].
Miyauchi A
Nihon Rinsho; 2006 Jun; Suppl 2():161-4. PubMed ID: 16817374
[No Abstract] [Full Text] [Related]
28. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
Cvitkovic F; Armand JP; Tubiana-Hulin M; Rossi JF; Warrell RP
Cancer J; 2006; 12(1):47-53. PubMed ID: 16613662
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia of malignancy: diagnosis and therapy.
Fetchick DA; Mundy GR
Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551
[TBL] [Abstract][Full Text] [Related]
31. [Hypercalcemia in malignant diseases. Physiopathology and treatment].
Aasarød K; Lamvik J
Tidsskr Nor Laegeforen; 1989 Apr; 109(12):1293-6. PubMed ID: 2734758
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
33. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
34. Management of severe hypercalcemia.
Davis KD; Attie MF
Crit Care Clin; 1991 Jan; 7(1):175-90. PubMed ID: 2007213
[TBL] [Abstract][Full Text] [Related]
35. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
Small EJ; Smith MR; Seaman JJ; Petrone S; Kowalski MO
J Clin Oncol; 2003 Dec; 21(23):4277-84. PubMed ID: 14581438
[TBL] [Abstract][Full Text] [Related]
36. Hypercalcemia. How to pinpoint the cause and customize treatment.
Kaye TB
Postgrad Med; 1995 Jan; 97(1):153-5, 159-60. PubMed ID: 7816712
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis and management of cancer associated hypercalcaemia.
Ralston SH
Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcemia and cancer: an update.
Murray TM; Josse RG; Heersche JN
Can Med Assoc J; 1978 Oct; 119(8):915-20. PubMed ID: 367555
[TBL] [Abstract][Full Text] [Related]
39. [Current use of bisphosphonates in clinical oncology].
Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
[TBL] [Abstract][Full Text] [Related]
40. [Hypercalcemia as an emergency].
Rosenmund A
Schweiz Med Wochenschr; 1993 Apr; 123(15):735-8. PubMed ID: 8488377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
